首页 | 本学科首页   官方微博 | 高级检索  
     

视网膜母细胞瘤的治疗进展
引用本文:朱柯宇,刘 春,王露瑶,段俊国. 视网膜母细胞瘤的治疗进展[J]. 现代肿瘤医学, 2023, 0(8): 1563-1567. DOI: 10.3969/j.issn.1672-4992.2023.08.033
作者姓名:朱柯宇  刘 春  王露瑶  段俊国
作者单位:成都中医药大学眼科学院/附属银海眼科医院,四川 成都 610072
基金项目:National Natural Science Foundation of China(No.82074335);国家自然科学基金资助项目(编号:82074335)
摘    要:
视网膜母细胞瘤(retinoblastoma,RB)是婴幼儿最常见的原发性恶性肿瘤,也是第二大眼内恶性肿瘤。一个完整的面部外观、视力对儿童的心理健康和将来的生活工作尤为重要。在保证生命的前提下提高保眼率是视网膜母细胞瘤治疗的关键,本文对目前国内外视网膜母细胞的治疗现状及进展进行综述。

关 键 词:视网膜母细胞瘤  婴幼儿  治疗

Progress in the treatment of retinoblastoma
ZHU Keyu,LIU Chun,WANG Luyao,DUAN Junguo. Progress in the treatment of retinoblastoma[J]. Journal of Modern Oncology, 2023, 0(8): 1563-1567. DOI: 10.3969/j.issn.1672-4992.2023.08.033
Authors:ZHU Keyu  LIU Chun  WANG Luyao  DUAN Junguo
Affiliation:Eye School of Chengdu University of Traditional Chinese Medicine/Ineye Hospital of Chengdu University of Traditional Chinese Medicine,Sichuan Chengdu 610072,China.
Abstract:
Retinoblastoma (RB) is the most common primary malignant tumor in infants and the second largest intraocular malignant tumor.A complete facial appearance and vision are particularly important for children's mental health and life.Therefore,improving eye preservation rate under the premise of ensuring life is the focus of RB treatment.This paper reviewed the current situation of RB treatment worldwide.
Keywords:retinoblastoma   infants   treatment
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号